Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China · Delayed Price · Currency is CNY 26.72
+0.04 (0.15%)
Apr 28, 2026, 3:00 PM CST
SHA:600566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,738 | 1,778 | 2,532 | 2,823 | 2,171 | 1,719 |
Depreciation & Amortization | 310.64 | 310.64 | 302.41 | 302.68 | 308.8 | 293.81 |
Other Amortization | 1.21 | 1.21 | 6.84 | 2.04 | 9.49 | 10.25 |
Loss (Gain) From Sale of Assets | -0.17 | -0.17 | -0.2 | -0.13 | -5.22 | -0.65 |
Asset Writedown & Restructuring Costs | -40.39 | -40.39 | 0.28 | 1.09 | 0.53 | 0.42 |
Loss (Gain) From Sale of Investments | -189.89 | -189.89 | -182.74 | -96.33 | -58.89 | -161.53 |
Provision & Write-off of Bad Debts | - | - | -22.16 | -3.04 | 36.02 | 8.28 |
Other Operating Activities | 142.95 | 16.32 | 35.21 | 21.68 | 31.75 | 32.77 |
Change in Accounts Receivable | -381.96 | -381.96 | 253.56 | 22.81 | -713.7 | -181.19 |
Change in Inventory | 258.95 | 258.95 | -81.9 | -98.6 | -15.89 | -97.17 |
Change in Accounts Payable | -555.79 | -555.79 | -698.68 | 476.51 | 856.54 | 269.44 |
Change in Other Net Operating Assets | 3.96 | 3.96 | 10.09 | 8.52 | -4.07 | -6.24 |
Operating Cash Flow | 1,285 | 1,198 | 2,176 | 3,464 | 2,621 | 1,894 |
Operating Cash Flow Growth | -21.26% | -44.94% | -37.17% | 32.17% | 38.35% | 6.32% |
Capital Expenditures | -263.99 | -95.86 | -174.34 | -301.64 | -243.66 | -248.32 |
Sale of Property, Plant & Equipment | 0.59 | 0.62 | 0.69 | 7.98 | 52.82 | 0.79 |
Investment in Securities | -3,442 | -1,072 | -1,951 | -182.68 | -1,380 | -474.89 |
Other Investing Activities | 187.67 | 190.64 | 84.81 | 82.12 | 67.53 | 49.11 |
Investing Cash Flow | -3,518 | -976.25 | -2,040 | -394.23 | -1,503 | -673.3 |
Short-Term Debt Issued | - | - | 1,442 | 1,095 | 400 | - |
Long-Term Debt Issued | - | 1,436 | - | - | - | - |
Total Debt Issued | 1,978 | 1,436 | 1,442 | 1,095 | 400 | - |
Short-Term Debt Repaid | - | - | -1,406 | -400 | -7.52 | -0 |
Long-Term Debt Repaid | - | -945.34 | -1.4 | -1.48 | -1.79 | -1.82 |
Total Debt Repaid | -1,268 | -945.34 | -1,407 | -401.48 | -9.31 | -1.82 |
Net Debt Issued (Repaid) | 710.16 | 490.22 | 34.71 | 693.96 | 390.69 | -1.82 |
Issuance of Common Stock | 26.84 | 20.24 | - | 14.21 | 97.18 | 50 |
Repurchase of Common Stock | - | - | -22.18 | -35.67 | - | - |
Common Dividends Paid | -1,932 | -1,929 | -1,218 | -823.19 | -605.45 | -409.37 |
Other Financing Activities | -57.88 | -34.15 | - | - | - | - |
Financing Cash Flow | -1,253 | -1,452 | -1,205 | -150.69 | -117.58 | -361.19 |
Foreign Exchange Rate Adjustments | -0.02 | -0.01 | - | - | - | - |
Net Cash Flow | -3,486 | -1,230 | -1,069 | 2,919 | 999.94 | 859.84 |
Free Cash Flow | 1,021 | 1,102 | 2,002 | 3,162 | 2,377 | 1,646 |
Free Cash Flow Growth | -32.76% | -44.94% | -36.69% | 33.03% | 44.42% | 21.74% |
Free Cash Flow Margin | 17.30% | 17.73% | 24.97% | 32.76% | 26.42% | 21.57% |
Free Cash Flow Per Share | 1.11 | 1.20 | 2.18 | 3.45 | 2.62 | 1.83 |
Cash Income Tax Paid | 1,052 | 1,087 | 1,464 | 1,650 | 1,264 | 1,177 |
Levered Free Cash Flow | 1,114 | 1,196 | 1,296 | 2,278 | 1,640 | 1,012 |
Unlevered Free Cash Flow | 1,114 | 1,196 | 1,313 | 2,289 | 1,659 | 1,034 |
Change in Working Capital | -677.69 | -677.69 | -494.75 | 413.18 | 127.6 | -8.19 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.